CAS: 1258417-54-7
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | ACT-389949 REF: TM-T10242CAS: 1258417-54-7 | 99.40% | 97,00 €~843,00 € | Mar 04 Mar 25 |
 | N-(2-((4-(1,1-Difluoroethyl)oxazol-2-yl)methyl)-2H-1,2,3-triazol-4-yl)-2-methyl-5-(m-tolyl)oxazole-4-carboxamide REF: IN-DA01N18BCAS: 1258417-54-7 | 98% | Prezzo su richiesta | Mar 04 Mar 25 |
 | ACT-389949 REF: 3D-IAC41754CAS: 1258417-54-7 | Min. 95% | Prezzo su richiesta | Mar 15 Apr 25 |
ACT-389949
CAS:1258417-54-7
ACT-389949: Potent, selective FPR2/ALX agonist; EC50 3 nM; potential inflammatory disorder treatment.
Formula:
C20H18F2N6O3
Purezza:
99.40%
Colore e forma:
Solid
Peso molecolare:
428.39
Ref: TM-T10242
| 1mg | 97,00 € | ||
| 5mg | 144,00 € | ||
| 10mg | 215,00 € | ||
| 25mg | 378,00 € | ||
| 50mg | 562,00 € | ||
| 100mg | 843,00 € |
Consegna stimata in Stati Uniti, il Martedì 04 Marzo 2025
N-(2-((4-(1,1-Difluoroethyl)oxazol-2-yl)methyl)-2H-1,2,3-triazol-4-yl)-2-methyl-5-(m-tolyl)oxazole-4-carboxamide
CAS:1258417-54-7
Formula:
C20H18F2N6O3
Purezza:
98%
Colore e forma:
Solid
Peso molecolare:
428.3921
Ref: IN-DA01N18B
| 5mg | 140,00 € | ||
| 10mg | 162,00 € | ||
| 25mg | 298,00 € | ||
| 50mg | 608,00 € |
Consegna stimata in Stati Uniti, il Martedì 04 Marzo 2025
ACT-389949
CAS:1258417-54-7
ACT-389949 is a novel small molecule that has been shown to be a potent inhibitor …
Formula:
C20H18F2N6O3
Purezza:
Min. 95%
Peso molecolare:
428.4 g/mol
Ref: 3D-IAC41754
| 25mg | 1.073,00 € | ||
| 50mg | 1.493,00 € | ||
| 100mg | 2.388,00 € |
Consegna stimata in Stati Uniti, il Martedì 15 Aprile 2025
